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Abstract
Background: It is known that when barefoot, gait biomechanics of diabetic neuropathic patients differ from non-
diabetic individuals. However, it is still unknown whether these biomechanical changes are also present during
shod gait which is clinically advised for these patients. This study investigated the effect of the participants own
shoes on gait biomechanics in diabetic neuropathic individuals compared to barefoot gait patterns and healthy
controls.
Methods: Ground reaction forces and lower limb EMG activities were analyzed in 21 non-diabetic adults (50.9 ±
7.3 yr, 24.3 ± 2.6 kg/m
2) and 24 diabetic neuropathic participants (55.2 ± 7.9 yr, 27.0 ± 4.4 kg/m
2). EMG patterns of
vastus lateralis, lateral gastrocnemius and tibialis anterior, along with the vertical and antero-posterior ground
reaction forces were studied during shod and barefoot gait.
Results: Regardless of the disease, walking with shoes promoted an increase in the first peak vertical force and the
peak horizontal propulsive force. Diabetic individuals had a delay in the lateral gastrocnemius EMG activity with no
delay in the vastus lateralis. They also demonstrated a higher peak horizontal braking force walking with shoes
compared to barefoot. Diabetic participants also had a smaller second peak vertical force in shod gait and a delay
in the vastus lateralis EMG activity in barefoot gait compared to controls.
Conclusions: The change in plantar sensory information that occurs when wearing shoes revealed a different
motor strategy in diabetic individuals. Walking with shoes did not attenuate vertical forces in either group. Though
changes in motor strategy were apparent, the biomechanical did not support the argument that the use of shoes
contributes to altered motor responses during gait.
Background
Many studies have been performed examining changes
in gait biomechanics of diabetic neuropathic populations
[1-7]. The previous described gait alterations are sus-
pected to predispose diabetic neuropathic patients to
foot ulcer formation.
The main changes in gait biomechanics caused by the
presence of peripheral diabetic neuropathy include
higher plantar pressures [8-11], alterations in spatio-
temporal patterns [1,4,12-15] and greater stance phase
time [2,5,6]. Kinetic parameters changes during gait
have also been observed and include modified ground
reaction forces and moments of force [1,2,4,12,16-18], as
well as decreased and delayed lower limb muscle activ-
ity. In particular, the vastus lateralis, tibialis anterior,
and gastrocnemius have been the most affected by the
neuropathy progression [3,5-7]. All of these alterations
may play an important role in foot ulcer formation, in
addition to other autonomic complications[19,20].
All of the previously discussed gait alterations have
been studied during barefoot gait, which does not repre-
sent the usual daily living locomotion condition,
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any medium, provided the original work is properly cited.especially among diabetic individuals. However, it is still
unknown if these biomechanical changes are also pre-
sent during shod gait, which is highly recommended for
diabetic patients to prevent foot ulceration. It is known
that the use of shoes changes the sensory input to the
motor control system [21-24] and it also may alter the
already reduced plantar sensitivity caused by the diabetic
neuropathy, which could modify the motor responses
and adjustments of these participants during load
accommodation. In other words, there may be addi-
tional biomechanical changes during shod gait that
would attempt to protect the foot and lower limbs
against overloads. The biomechanical adjustments dur-
ing shod gait in patients with diabetic neuropathy are
not yet clear.
Although the use of footwear is considered an impor-
tant factor to prevent diabetic foot ulcers (due to its
effect on plantar pressure redistribution), there are no
studies that compares biomechanical gait patterns in
diabetic individuals with and without shoes. These para-
meters have already been compared in patients with
knee osteoarthritis [25], after knee ligament reconstruc-
tion [26] and in runners [27], some of them favour the
barefoot condition for load attenuation of the injured
joint [25,26,28,29].
There are several mechanisms by which footwear may
influence lower limb biomechanics. It has been sug-
gested that less ankle range of motion caused by the use
of shoes may partially block the foot rollover process
that could alter the rocker action of the foot and ankle
necessary for normal function and biomechanics of the
lower limbs [30]. One of the consequences of reduced
range of motion during gait is a loss of the ankle’s
eccentric control occurring from heel strike to flat foot
phase that can cause an alteration in the shock absorp-
tion mechanism and may increase loads applied to the
foot of diabetic patients [31].
Other findings suggest that during barefoot gait the
longitudinal plantar arch seems to be higher, potential
causing a more enhanced load accommodation [32,33].
The higher plantar arch observed when walking barefoot
could be due to a motor strategy attempting to change
the plantar architecture for better shock absorption.
Adequate afferent information, from the plantar surface
of the foot during contact with the floor, is an essential
element for these foot adaptations and may be altered
when wearing shoes [27,32,33]. In the shod condition,
the plantar arch loses its full capacity for load attenua-
tion [27] due to the alterations in afferent information
and the lack of malleability caused by the shoes. This
loss of load attenuation capacity can be related to the
high injury frequency in shod locomotion conditions
[27,33].
This study aimed to comparing ground reaction forces
and lower limb muscle activity (EMG) during gait with
and without the use of regular shoes worn on a daily
basis between diabetic neuropathic individuals and
healthy controls. It was hypothesized that walking with
shoes influences the plantar sensory information avail-
able, resulting in altered ground reaction forces and
delayed muscle activity.
Methods
Subjects
Forty-five adult volunteers participated in this study and
were divided into two groups: a control group (CG)
composed of 21 healthy non-diabetic participants (age =
50.9 ± 7.3 yr, BMI = 24.3 ± 2.6 kg/m
2) and 24 diabetic
neuropathic participants (DG) (age = 55.2 ± 7.9 yr, BMI
= 27.0 ± 4.4 kg/m
2). Ethics approval was obtained from
the Local Ethics Committee. The volunteers provided
written informed consent to participate in the study. All
neuropathic participants were diagnosed by a physician.
Inclusionary criteria consisted of: at least 5 years post-
onset of Type 2 diabetes, a minimum of two plantar
areas with deficits on tactile sensitivity by not recogniz-
ing a 10 g monofilament [10,34,35] and a score higher
than 6 in the Michigan Neuropathy Screening Instru-
ment - questionnaire (MNSI-q) for symptoms related to
the diabetic neuropathy [36]. The exclusion criteria
adopted for both groups included an age over 65, due to
alterations in gait simply caused by aging, partial or total
amputation, orthopedic disorders of the lower limbs,
pain during the data collection, use of any assistive
devices for walking (walking sticks/canes) and the pre-
sence of plantar ulcers at the time of the evaluation.
Procedure
EMG activity of right vastus lateralis (VL), lateral gastro-
cnemius (GL) and tibialis anterior (TA) muscles and
ground reaction forces were collected simultaneously
during the stance phase of both barefoot and shod gait.
Participants were requested to walk both barefoot and
using their habitual shoes (the shoes they used most fre-
quently during daily activities) at a self-selected cadence
across a 10 m walkway with a force plate embedded in
its center. EMG activity was sampled at 1000 Hz during
three trials in each gait condition using the EMG Sys-
tem do Brasil (Sao José dos Campos, Brazil). The bipolar
surface electrodes were placed according to SENIAM
recommendations [37]. Electrode diameter was 10 mm
with an inter-electrode distance of 22 mm. After shaving
and cleaning each area with alcohol, electrodes were
attached to the skin using both Transpore adhesive tape
(3 M, Sumaré, Brazil) and an elastic band (Tensor,
Cotia, Brazil). The vertical and horizontal antero-poster-
ior ground reaction forces (GRF) were collected using
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Hz.
To reduce variability, the type of shoes were con-
trolled and matched for both groups, so that the groups
wore proportionally the same kind of shoes: sport shoes
(30%), loafers (30%), sandals (25%) and dress shoes
(15%). None of the participants used customized ortho-
pedic/therapeutic shoes on a daily basis.
Numerical and Statistical analysis
For the EMG data, first the DC offsets were removed,
the signals were then full-wave rectified, and passed
through a zero lag 4
th order Butterworth low-pass filter
with a cutoff frequency of 5 Hz. Finally the EMG signals
were time normalized to 100% of the stance phase,
which was determined using the GRF. The GRF data
were processed using a zero lag low-pass Butterworth
4
th order filter with a cutoff frequency of 100 Hz and
then normalized to each subject’s body weight and also
time normalized to 100% of the stance phase.
All data were processed and variables were calculated
in a custom-written program using Matlab v.7.1 (Math-
Works, Inc.). The EMG variables for the TA, VL and
LG muscles were time to peak EMG during the stance
phase of gait. The vertical GRF variables consisted of
the first and second peaks vertical force and the mini-
mum value between the two peaks. The antero-posterior
GRF variables consisted of the peak braking horizontal
force and the peak propulsive force.
Levene test and Shapiro-Wilks test were used to assess
each variables homocedasticity and that each one was nor-
mally distributed. Statistical tests included a 2 (group) × 2
(condition) analysis of variance (ANOVA) to assess the
EMG and GRF variables. The Newman-Keuls post hoc
test was used following each of the ANOVAs (a =0 . 0 5 ;
0.05 < a < 0.10 = trend to significant different variables).
Results
When examining stance phase time the results demon-
strated that there was no significant difference between
the groups for both gait conditions (CG × DG shod p =
0.10; barefoot p = 0.33) This was performed to verify
that both groups presented with similar gait cadence,
once differences in stance phase could be caused by dif-
ferent cadences adopted by the subjects.
The results for time to peak EMG are presented in
Table 1, Figure 1, Figure 2 and Figure 3 for both condi-
tions (shod and barefoot gait).
The results for vertical and horizontal GRF are pre-
s e n t e di nT a b l e2 ,F i g u r e4 ,F i g u r e5a n dF i g u r e6f o r
both groups during each of the gait conditions.
Once there was no significant Group × Condition
interaction effects in the statistical analysis, in the
results are presented first the Group effect then the
Condition effect.
Group effect
There was a significant group effect in the VL time to
peak EMG [F(1,32) = 5.12; p = 0.03] and in the second
peak vertical GRF [F(1,32) = 6.68; p = 0.01]. The VL
muscular activity showed a marginally significant differ-
ence in group × condition interaction effect [F(1,32) =
3.74, p = 0.06]. Diabetic participants presented with a
delayed VL activity comparing to controls during bare-
foot gait (p = 0.005) which was found to be 3.5% of the
stance phase (23 ms). Diabetic participants also demon-
strated a 6% of body weight reduction during the shod
gait condition for the second peak vertical GRF com-
pared to controls (p = 0.01).
Condition effect
There was a significant effect for condition in the VL
time to peak EMG [F(1,32) = 10.68; p = 0.002], GL [F
(1,32) = 10.98; p = 0.002] and a strong trend for TA
time to peak EMG [F(1,32) = 3.63; p = 0.06]. During
shod gait, there was a significant delay in the LG activity
among diabetic participants (p = 0.03, post hoc test) and
a delay in the VL activity among controls (p = 0.004,
post hoc test). The delay in the LG activity was 3% of
the stance phase among diabetic participants (approxi-
mately 21 ms) and the delay in the VL activity was 5%
among controls (approximately 35.2 ms).
There was a significant effect for condition in the first
peak vertical GRF [F(1,32) = 22.42; p < 0.001], peak
braking force [F(1,32) = 14.58; p < 0.001] and peak pro-
pulsive force [F(1,32) = 25.18; p < 0.001]. The first peak
vertical GRF was significantly higher in both groups
during the shod gait condition. The difference between
both gait conditions among diabetic participants was
found to be 5% of body weight higher (p = 0.01, post
hoc test) and among the controls was found to be 4% of
body weight (p = 0.003, post hoc test). Peak braking and
propulsive forces were also higher in diabetic partici-
pants during shod gait (braking force was 3% of body
weight, p = 0.002; propulsive force was 1.5% of body
w e i g h t ,p=0 . 0 1 ,p o s th o ct e s t ) .A m o n gc o n t r o l s ,o n l y
the peak propulsive force was higher during shod gait
(2% above body weight, p = 0.002, post hoc test).
Discussion
The present study investigated whether ground reaction
forces and lower limb EMG activity were altered during
gait with and without the use of regular shoes worn on
a daily basis between diabetic neuropathic individuals
and healthy controls. To date, the authors are unaware
of any current literature that supports the role of shoes
in modifying muscular responses or altering GRF during
diabetic neuropathic gait. The main results support our
initial hypotheses that walking with shoes used on a
daily basis, delays lower limb muscle activity and alters
vertical and horizontal ground reaction forces. However,
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a d j u s t m e n t sd u r i n gs h o dg a i tc o m p a r e dt oc o n t r o l s
since their muscle activation was already delayed in
barefoot gait.
The results of this study showed that when walking
with shoes, both control and diabetic participants pre-
sented with a higher vertical peak GRF at initial ground
contact and a higher propulsive force. The smaller
vertical peak GRF and propulsive force during barefoot
gait could be caused by a more precautious gait adopted
by both groups. The results from the first vertical peak
during shod gait contradict the popular belief that the
use of shoes attenuates external loads during walking,
particularly in diabetic neuropathic subjects. Hennig et
al. (1994) have also contradicted these beliefs. They
observed that the first vertical peak GRF was lower
Table 1 Mean (and standard deviation) of Vastus lateralis, Lateral gastrocnemius and Tibialis anterior time of peak
occurrence of control group (CG) and diabetic group (DG), during the stance phase in both condition group: barefoot
and shod gait.
ANOVA Effect size
Time of peak
occurrence (%)
Condition CG (n =
21)
DG (n =
24)
Group Condition Group ×
Condition
DG relative to CG
(95% CI)
Shod relative to
Barefoot (95% CI)
Vastus lateralis Shod 15.47 ±
4.27
15.35 ±
3.71
F=
5.12
F = 10.68 F = 3.74 -0.120 (- 2.809 to
2.569)
2.960 (1.305 to 4.614)
Barefoot 10.76 ±
2.81
14.14 ±
2.35
p=
0.030
p = 0.002 p = 0.06 3.380 (1.639 to
5.121)
Lateral
gastrocnemius
Shod 66.41 ±
4.31
68.23 ±
3.84
F=
1.29
F = 10.98 F = 0.20 -1.820 (-0.813 to
4.453)
2.590 (0.528 to 4.652)
Barefoot 64.17 ±
3.92
65.29 ±
5.35
p=
0.263
p = 0.002 p = 0.654 1.120 (- 2.033 to
4.273)
Tibialis anterior Shod 6.52 ±
3.08
6.58 ±
2.82
F=
0.20
F = 3.36 F = 0.06 0.060 (-1.925 to
2.045)
1.020 (-0.216 to 2.256)
Barefoot 5.46 ±
2.36
5.61 ±
2.39
p=
0.655
p = 0.06 p = 0.804 0.150 (-1.447 to
1.746)
Effect size (mean difference (95% CI)) is also provided for each variable.
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Figure 1 Mean of the linear envelopes of the right vastus lateralis muscle (VL), normalized according to the mean of the control (CG)
and diabetic (DG) groups during shod and barefoot gait. Note the delayed peak in CG shod, DG barefoot and shod gait conditions.
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perception cushioning scale. Diverti et al. (2005) ana-
lyzed ground reaction forces during barefoot and shod
running and also found lower values during the barefoot
condition, which is typically considered the harder con-
dition. The authors have suggested that barefoot run-
ning leads to a reduction of the initial impact peak due
to a neural-mechanical adaptation in order to reduce
high mechanical stress occurring during repetitive steps.
Shakoor and Block (2006) found lower knee forces
during barefoot gait in participants with osteoarthritis
compared to shod gait (habitual shoes). The authors
suggested that walking barefoot may increase proprio-
ceptive inputs from skin contact with the ground, lead-
ing to a more precautious gait pattern. In this study, the
diabetic group had a pre-existing afferent deficit in the
plantar surface of the foot. Walking barefoot may have
increased the proprioceptive inputs causing an enhanced
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Figure 2 Mean of the linear envelopes of the right lateral gastrocnemius muscle (GL), normalized according to the mean of the
Control (CG) and diabetic (DG) groups during shod and barefoot gait.
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Figure 3 Mean of the linear envelopes of the right tibialis anterior muscle (TA), normalized according to the mean of the Control (CG)
and diabetic (DG) groups during shod and barefoot gait.
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Page 5 of 9efferent pattern, which may have decreased the values of
the first vertical peak in an attempt to reduce joint
loads.
The second vertical peak was smaller in the diabetic
group compared to the control group when wearing
shoes. However, this difference was not observed during
barefoot gait. Since no changes in GL muscle activity
was observed between groups, the use of shoes may be
partially blocking the foot roll over process and
restricting normal ankle motion, which is already altered
in the diabetic population [38-42]. This could modify
the foot rollover mechanism during propulsion phase,
that corresponds to the phase in which the second peak
occurs and may have influenced its magnitude.
There were no differences in antero-posterior GRF
peaks between groups in either gait condition. However,
when comparing gait conditions the diabetic group had
a higher horizontal braking force when wearing shoes,
which is similar to the higher vertical peak during the
initial stance phase. The diabetic individuals may be
adopting a strategy to increase the sensitive inputs by
increasing the force when they contact their heel to the
floor. Also, the diabetics presented a delayed VL activity
compared to controls, which may cause a higher braking
force.
The alterations in sensorimotor control, due to the
use of shoes, were different in controls compared to dia-
betic participants. The neuromuscular system will gener-
ate responses according to the afferent sensory
information caused by mechanical loads placed on the
foot. Considering the reduced plantar sensitivity in the
diabetic neuropathic participants, it is possible that the
muscle recruitment strategy to attenuate joint loads is
altered in these patients. Due to the decreased plantar
sensitivity, changes in EMG and external loads would be
expected [2,3,5-7] and were observed in the present
study.
Table 2 Mean (and standard deviation) of frst, second and minimum value between these vertical GRF peaks, braking
and propulsion GRF peaks of control group (CG) and diabetic group (DG), during the stance phase in both condition
group: barefoot and shod gait.
ANOVA Effect size
GRF (times
bodyweight)
Condition CG (n =
21)
DG (n =
24)
Group Condition Group ×
Condition
DG relative to CG
(95% CI)
Shod relative to
Barefoot (95% CI)
First Vertical Peak Shod 1.09 ±
0.09
1.12 ±
0.07
F=
1.29
F = 22.42 F = 0.11 0.030 (- 0.024 to
0.084)
0.040 (0.004 to 0.075)
Barefoot 1.04 ±
0.09
1.08 ±
0.06
p=
0.262
p < 0.001 p = 0.742 0.040 (-0.011 to
0.091)
Second Vertical Peak Shod 1.11 ±
0.07
1.05 ±
0.05
F=
6.68
F = 3.15 F = 0.80 - 0.060 (- 0.101 to -
0.019)
0.0200 (-0.011 to 0.051)
Barefoot 1.09 ±
0.07
1.04 ±
0.07
p=
0.014
p = 0.085 p = 0.378 - 0.050 (- 0.097 to -
0.003)
Minimum value
between peaks
Shod 0.77 ±
0.07
0.76 ±
0.07
F=
0.64
F = 8.97 F = 0.002 - 0.010 (- 0.057 to
0.037)
-0.030(-0.061 to 0.001
Barefoot 0.81 ±
0.08
0.81 ±
0.07
p=
0.428
p = 0.005 p = 0.967 0.000 (- 0.051 to
0.051)
Braking force Shod -0.142 ±
0.04
-0.152 ±
0.05
F=
0.02
F = 14.58 F = 2.81 - 0.010 (- 0.040 to
0.020)
-0.020 (-0.032 to -0.008)
Barefoot -0.131 ±
0.02
-0.125 ±
0.04
p=
0.873
p < 0.001 p = 0.103 0.006 (- 0.015 to
0.027)
Propulsion force Shod 0.178 ±
0.02*
0.168 ±
0.03
F=
0.64
F = 25.18 F = 0.68 - 0.010 (- 0.027 to
0.007)
0.020 (0.011 to 0.029)
Barefoot 0.155 ±
0.02*
0.152 ±
0.03
p=
0.428
p < 0.001 p = 0.412 - 0.003 (- 0.020 to
0.014)
Effect size (mean difference (95% CI)) is also provided for each variable.
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Figure 4 Mean of vertical GRF curves in shod gait condition
normalized according to each participant’s body weight of the
control (CG) and diabetic (DG) groups. Note the lower second
vertical peak in DG.
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and altered afferent sensory information has lead to
adjustments in efferent muscular responses, which mod-
ified the lower limb biomechanical kinetic parameters. It
was not only the use of shoes that caused these changes,
nor the sensorial deficit isolated, but their interaction.
It has previously been shown that changing the affer-
ent information of the plantar surface during gait can
alter lower limb muscle activity [43]. Therefore, a
delayed muscular activation pattern during shod gait in
all participants was expected, especially at initial ground
c o n t a c tw h e nt h ea f f e r e n ti n f o r m a t i o ni se v e nm o r e
altered with shoes [21-23]. The expected neuromuscular
delays are thought to be related to the muscles involved
in shock attenuation, which include the quadriceps
femoris and tibialis anterior [44]. In the present study,
the healthy participants had a delay in the VL at initial
ground contact with shoes compared to barefoot. The
diabetic group did not have a delay in the VL activity at
initial ground contact between the shod and barefoot
conditions. However, the diabetic group kept the same
pattern of VL activation when wearing shoes compared
to walking barefoot, they had a delayed VL activation
compared to the control group. During the shod condi-
tion, only the diabetic group had a delay of the GL
activity, which may demonstrate an altered sensorimotor
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Figure 5 Mean of vertical GRF curves in shod and barefoot gait condition normalized according to each participant’s body weight of
the diabetic (DG) and control group (CG). Note the lower first vertical peak in barefoot condition in both groups.
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Figure 6 Mean of braking and propulsion GRF curves in shod and barefoot gait condition normalized according to each participant’s
body weight of the diabetic (DG) and control group (CG). Note the higher braking force in shod condition in both groups, and the higher
propulsion force in shod condition in CG.
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information wearing shoes. This demonstrates that the
decreased plantar sensitivity caused by the disease may
have a greater effect on the neuromuscular control than
the afferent changes seen with the use of shoes.
There was no effect of the disease or the gait condi-
tion on TA activity. This finding is in agreement with
previous results that did not find any delays in TA [6,7].
However, the current results also conflict with other
studies [3,5]. Sacco and Amadio (2003) found subtle
delays in the TA EMG activity of diabetics (around 6%
of the stance phase), which justify further studies to
investigate the temporal organization of the TA activa-
tion in the stance phase.
There are some limitations to the present study, which
should be identified. Although shoe type was attempted
to be controlled and matched between groups, it may
have added some variability to the EMG and GRF data.
A universal shoe was not used due to the need for each
participant to adapt to a new pair of shoes, which may
interfere with the biomechanical data.
The present results reveal that the pattern of muscle
activation in the stance phase of diabetic individuals is
still a matter of debate, as put forward by Allet et al.
(2008)[45]. The study of the EMG time series and its
relation to recruitment firing rate will contribute to elu-
cidate the locomotor pattern in neuropathic diabetic
subjects.
The altered patterns exhibited by neuropathic partici-
pants in adapting motor strategies when with or without
shoes may also be present in other daily tasks. There-
fore, an interesting way to improve the knowledge about
the strategies adopted by diabetic neuropathic indivi-
duals is challenging their neuromuscular system by
inducing voluntary increases in the cadence or perform-
ing other daily living activities, such as go up- or down-
stairs. A better understanding of the muscle activation
pattern of neuropathic diabetic individuals during loco-
motor tasks is important for a suitable therapeutic inter-
vention that aims for a better foot-floor interaction
which can contribute to the prevention of plantar
ulcerations.
Conclusions
The use of shoes in diabetic neuropathic participants
did not result in any delay of vastus lateralis activity
compared with the non-diabetic participants, however
there was a delay in the lateral gastrocnemius activation.
The use of shoes did not reduce the vertical ground
reaction forces at heel strike in diabetics and healthy
controls. Furthermore, the results of the present study
did not find any biomechanical data to support the
notion that diabetic participants adjust their motor
responses due to the use of shoes, although the use of
shoes is highly recommended for diabetics to prevent
distal lower limb injuries.
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